Table 2—

Age-specific and age-standardized prevalence with 95% CIs of IFG and type 2 diabetes among 475 men and 660 women in the Khagrachari study, 2002

Prevalence (95% CI)
Age specific (years)
Age standardized (years)
20–2930–3940–4950–59≥6020–70
Diabetes
 Men2.4 (0.28–5.00)3.5 (0.39–7.37)7.6 (2.19–13.03)14.1 (5.55–22.58)19.4 (9.93–28.87)7.4 (5.04–9.67)
 Women3.0 (0.42–5.62)5.4 (2.15–8.66)6.7 (2.20–11.13)11.1 (3.35–18.87)5.5 (0.26–10.70)5.5 (3.71–7.34)
 All2.8 (0.58–4.96)4.6 (1.80–7.34)7.0 (3.15–10.72)15.1 (7.79–22.32)13.4 (7.09–19.70)*6.4 (4.96–7.87)
IFG
 Men5.4 (0.54–3.42)11.5 (0.77–4.94)4.1 (1.39–10.98)4.5 (5.10–20.99)11.8 (8.90–26.24)7.3 (4.08–8.08)
 Women9.6 (4.44–14.76)9.5 (4.92–14.06)9.0 (3.39–14.61)10.2 (1.73–18.68)8.2 (1.31–15.08)9.4 (6.76–12.08)
 All7.8 (4.26–11.41)10.0 (6.06–14.03)6.9 (3.15–10.72)7.5 (2.16–12.86)9.8 (4.31–15.33)*8.4 (6.48–10.37)
  • Age adjustment was based on the adjusted census of 1996. IFG is FPG 6.1–6.9 mmol/l. Diabetes is FPG ≥7.0 mmol/l.

  • *

    * χ2 for trend, P < 0.001.